Chemokine expression in GKO mice (lacking interferon-gamma) with experimental autoimmune encephalomyelitis

Journal of NeuroVirology

Volumn 5, Issue 1, 1999, Pages 95-101

  Glabinski, Andrzej R ^a,b   Krakowski, Michelle ^c   Han, Yulong ^a   Owens, Trevor ^c   Ransohoff, Richard M ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b MEDICAL UNIVERSITY OF LODZ   (Poland)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

Chemotactic factors; Demyelinating diseases; Knockout; Mice; Type II interferon

Indexed keywords

CHEMOKINE; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; MONOCYTE CHEMOTACTIC PROTEIN 1; UNCLASSIFIED DRUG;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; CENTRAL NERVOUS SYSTEM DISEASE; CONTROLLED STUDY; DEMYELINATING DISEASE; INFLAMMATORY CELL; INFLAMMATORY DISEASE; KNOCKOUT MOUSE; MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; PRIORITY JOURNAL;

ANIMALIA;

EID: 0032892658     PISSN: 13550284     EISSN: None     Source Type: Journal    
DOI: 10.3109/13550289909029750     Document Type: Article

References (37)

1. Asensio VC, Campbell IL (1997). Chemokine gene expression in the brains of mice with lymphocytic choriomeningitis. J Virol 71: 7832-7840.
2. Billiau A, Heremans H, Vandekerckhove F, Dijkmans R, Sobis H, Meulepas E, Carton H (1988). Enhancement of experimental allergic encephalomyelitis in mice by antibodies against IFN-gamma. J Immunol 140: 1506-1510.
3. Cheifetz S, Moscarello M, Deber C (1984). NMR investigation of the charge isomers of bovine myelin basic protein. Arch Biochem Biophys 233: 151-160.
4. Dalton D, Pitts-Meek S, Keshav S, Figari I, Bradley A, TA S (1993). Multiple defects of immune cell function in mice with disrupted interferon-gamma gene. Science 259: 1739-1742.
5. Duong T, Finkelman F, Singh B, Strejan G (1994). Effect of anti-interferon-gamma monoclonal antibody treatment on the development of experimental allergic encephalomyelitis in resistant mouse strains. J Neuroimmunol 53: 101-107.
6. Ferber I, Brocke S, Taylor-Edwards C, Ridgway W, Dinisco C, Steinman L, Dalton D, Fathman C (1996). Mice with a disrupted IFN-gamma gene are susceptible to the induction of experimental autoimmune encephalomyelitis. J Immunol 156: 5-7.
7. Glabinski A, Tani M, Aras S, Stoler M, Tuohy V, Ransohoff R (1995a). Regulation and function of central nervous system chemokines. International J Dev Neurosci 13: 153-165.
8. Glabinski A, Tani M, Tuohy VK, Tuthill R, Ransohoff RM (1995b). Central nervous system chemokine gene expression follows leukocyte entry in acute murine experimental autoimmune encephalomyelitis. Brain Behav Immun 9: 315-330.
9. Glabinski A, Tani M, Strieter R, Tuohy V, Ransohoff R (1997). Synchronous synthesis of α- and β-chemokines by cells of diverse lineage in the central nervous system of mice with relapses of experimental autoimmune encephalomyelitis. Am J Pathol 150: 617-630.
10. Glabinski AR, Tani M, Balasingam V, Yong VW, Ransohoff RM (1996). Chemokine monocyte chemoattractant protein-1 (MCP-1) is expressed by astrocytes after mechanical injury to the brain. J Immunol 156: 4363-4368.
11. Goes N, Sims T, Urmson T, Vincent D, Ramassar V, Holloran P (1995). Disrupted MHC regulation in the IFN-gamma knockout mouse. Evidence for three states of MHC expression with distinct roles for IFN-gamma. J Immunol 155: 4559-4566.
12. Gourmala NG, Buttini M, Limonta S, Sauter A, Boddeke HW (1997). Differential and time-dependent expression of monocyte chemoattractant protein-1 mRNA by astrocytes and macrophages in rat brain: effects of ischemia and peripheral lipopolysaccharide administration. J Neuroimmunol 74: 35-44.
13. Hartung H, Schafer B, van der Meide P, Fierz W, Heininger K, Toyka K (1990). The role of interferon-gamma in the pathogenesis of experimental autoimmune disease of the peripheral nervous system. Ann Neurol 27: 247-257.
14. Hofman F, von Hanwehr R, Dinarello C, Mizel S, Hinten D, Merrill J (1986). Immunoregulatory molecules and IL-2 receptors identified in multiple sclerosis brain. J Immunol 136: 3239-3247.
15. Hofman FM, Hinton DR, Johnson K, Merrill JE (1989). Tumor necrosis factor identified in multiple sclerosis brain. J Exp Med 170: 607-612.
16. Horwitz M, Evans C, McGavern D, Rodriguez M, Oldstone M (1997). Primary demyelination in transgenic mice expressing interferon-gamma. Nature Med 3: 1037-1041.
17. Karpus WJ, Lukacs NW, McRae BL, Strieter RM, Kunkel SL, Miller SD (1995). An important role for the chemokine macrophage inflammatory protein-1α in the pathogenesis of the T cell-mediated autoimmune disease, experimental autoimmune encephalomyelitis. J Immunol 155: 5003-5010.
18. Kim JS, Gautam SC, Chopp M, Zaloga C, Jones ML, Ward PA, Welch KMA (1995). Expression of monocyte chemoattractant protein-1 and macrophage inflammatory protein-1 after focal cerebral ischemia in the rat. J Neuroimmunol 56: 127-134.
19. Krakowski M, Owens T (1996). Interferon-gamma confers resistance to experimental allergic encephalomyelitis. Eur J Immunol 26: 1641-1646.
20. Merrill J, Kono D, Clayton J, Ando D, Hinton D, Hofman F (1992). Inflammatory leukocytes and cytokines in the peptide-induced disease of experimental allergic encephalomyelitis in SJL and B10.PL mice. Proc Natl Acad Sci USA 89: 574-578.
21. Narumi S, Wyner L, Stoler M, Tannenbaum C, Hamilton T (1992). Tissue specific expression of murine IP-10 mRNA following systemic treatment with interferon-γ. J Leukocyte Biol 52: 27-33.
22. Ohmori Y, Hamilton TA (1994). IFN-gamma selectivity inhibits lipopolysaccharide-inducible JE/monocyte chemoattractant protein-1 and KC/GRO/melanoma growth-stimulating activity gene expression in mouse peritoneal macrophages. J Immunol 153: 2204-2212.
23. Panitch HS, Hirsch RL, Haley AS, Johnson KP (1987a). Exacerbations of multiple sclerosis in patients treated with gamma interferon. Lancet 1: 893-895.
24. Panitch HS, Hirsch RL, Schindler J, Johnson KP (1987b). Treatment of multiple sclerosis with gamma interferon: exacerbations associated with activation of the immune system. Neurology 37: 1097-1102.
25. Ping D, Jones PL, Boss JM (1996). TNF regulates the in vivo occupancy of both distal and proximal regulatory regions of the MCP-1/JE gene. Immunity 4: 455-469.
26. Ransohoff R, Tani M, Glabinski A, Chernosky A, Krivacic K, Peterson J, Chien H, Trapp B (1997). Chemokines and chemokine receptors in model neurological pathologies: molecular and immunocytochemical approaches. Methods Enzymol 287: 319-348.
27. Ransohoff RM, Hamilton TA, Tani M, Stoler MH, Shick HE, Major JA, Estes ML, Thomas DM, Tuohy VK (1993). Astrocyte expression of mRNA encoding cytokines IP-10 and JE/MCP-1 in experimental autoimmune encephalomyelitis. FASEB J 7: 592-602.
28. Renno T, Krakowski M, Piccirillo C, Lin JY Owens T (1995). TNF-alpha expression by resident microglia and infiltrating leukocytes in the central nervous system of mice with experimental allergic encephalomyelitis. Regulation by Th1 cytokines. J Immunol 154: 944-953.
29. Romano M, Sironi M, Toniatti C, Polentarutti N, Fruscella P, Ghezzi P, Faggioni R, Luini W, van Hinsbergh V, Sozzani S, Bussolino F, Poli V, Ciliberto G, Mantovani A (1997). Role of IL-6 and its soluble receptor in induction of chemokines and leukocyte recruitment. Immunity 6: 315-325.
30. Selmaj K, Raine CS, Canella B, Brosnan CF (1991). Identification of lymphotoxin and tumor necrosis factor in multiple sclerosis lesions. J Clin Invest 87: 949-954.
31. Sethna M, Lampson L (1991). Immune modulation within the brain: recruitment of inflammatory cells and increased major histocompatibility antigen expression following intracerebral injection of interferon-gamma. J Neuroimmunol 34: 121-132.
32. Sharief M, Hentges R (1991). Association between tumor necrosis factor-alpha and disease progression in patients with multiple sclerosis. N Engl J Med 325: 467-471.
33. Simmons RD, Willenborg DO (1990). Direct injection of cytokines into the spinal cord causes autoimmune encephalomyelitis-like inflammation. J Neuro Sci 100: 37-42.
34. Tani M, Glabinski AR, Tuohy VK, Stoler MH, Estes ML, Ransohoff RM (1996). In situ hybridization analysis of glial fibrillary acidic protein mRNA reveals evidence of biphasic astrocyte activation during acute experimental autoimmune encephalomyelitis. Am J Pathol 148: 889-896.
35. Voorthuis J, Uitdehaag B, De Groot C, Goede P, van der Meide P, Dijkstra C (1990). Suppression of experimental allergic encephalomyelitis by intraventricular administration of interferon-gamma in Lewis rats. Clin Exp Immunol 81: 183-188.
36. Wojcik WJ, Swoveland P, Zhang X, Vanguri P (1996). Chronic intrathecal infusion of phosphorothioate or phosphodiester antisense oligonucleotides against cytokine responsive gene-2/IP-10 in experimental allergic encephalomyelitis of Lewis rat. J Pharmacol Exp Ther 278: 404-410.
37. Zhou L, Miller R (1998). Antibody-mediated oligodendrocyte cell death requires an astrocyte-derived cosignai. J Neurosci Res 52: 137-148.